Genetic variants of AKR1C3 gene were correlated with risk of lung and prostate cancer [34], leukemia [35], bladder cancer [36], B cell non-Hodgkin lymphoma, and breast cancer [37]. This evidence concerns the gene AKR1C3 and prostate cancer.